Turning complex
radiochemistry into
clinical reality.

Partner with Radiopharmium Ltd to navigate the challenges of radiopharmaceutical development. Our consultancy provides the insight, technical know-how, and collaborative support you need to advance your program with confidence and speed.

Contact Us

Consultancy Services

Radiopharmium Ltd offers expert consultancy across the full spectrum of radiopharmaceutical development — from early-stage R&D and preclinical studies to CMC activities optimized for technology transfer and clinical translation. We also facilitate strategic collaborations with academia, industry, and healthcare partners, ensuring your development pipeline progresses efficiently and successfully.

Research & Development

CMC

Clinical Translation
& GMP Production

Business & Partnership Development

For Startups & Innovators.

For Investors & Venture Capitalists.

At Radiopharmium Ltd, we provide Fractional Leadership services for startups and small to medium-sized organisations starting their journey. We bring experience and leadership without a full-time hire. We shape and execute strategy, oversee R&D, navigate complex regulatory pathways, build and lead teams, and engage investors and stakeholders. With our fractional CSO model, you gain high-performing, fit-for-purpose scientific leadership tailored to your needs.

We help investors make confident decisions in one of the most complex areas of life sciences. Our expertise bridges the gap between scientific innovation and clinical reality, ensuring your portfolio companies are set up for success.

How can we help? We work with venture capital firms, angel investors, and accelerators to ensure radiopharmaceutical projects are technically robust and strategically prepared. We do this by providing an independent assessment of the science behind the intellectual property, reviewing the scalability, CMC readiness and regulatory strategy of the technology - to identify strengths, opportunities and risk.